go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Rhode Island rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $575,440 · 10th–90th $562,341$1,819,7010%50%10th90th$575,440Professionalmedian $588,844 · 10th–90th $562,341$616,5950%50%10th90th$588,844$100.0K$200.0K$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,096,478.20
Median
$1,819,700.86
Typical High
$1,819,700.86
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$588,843.66
Typical High
$616,595.00
BCBS
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$588,843.66
BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$1,096,478.20
United
Setting
Professional
Modifier
Global
Typical Low
$61,659.50
Median
$346,736.85
Typical High
$616,595.00